A PD Study of Oral eFT508 in Subjects With Advanced TNBC and HCC
Clinical trial NCT03318562 · TERMINATED
Trial details
- NCT number
- NCT03318562
- Sponsor
- Effector Therapeutics
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-21
- Primary completion
- 2018-07-05
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.